印度阿育吠陀治疗缺血性卒中患者的康复:一项随机对照试验(RESTORE) -过程评估的结果。

IF 1.5 3区 医学 Q3 CLINICAL NEUROLOGY
Pheba Susan Raju, Shweta Jain Verma, Aneesh Dhasan, Deepti Arora, Jeyaraj Durai Pandian, Vivek Nambiar, Sunil Narayan, Veena Babu, Meenakshi Sharma, Padmavathy Narayanan Sylaja
{"title":"印度阿育吠陀治疗缺血性卒中患者的康复:一项随机对照试验(RESTORE) -过程评估的结果。","authors":"Pheba Susan Raju, Shweta Jain Verma, Aneesh Dhasan, Deepti Arora, Jeyaraj Durai Pandian, Vivek Nambiar, Sunil Narayan, Veena Babu, Meenakshi Sharma, Padmavathy Narayanan Sylaja","doi":"10.1159/000547133","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The RESTORE trial was the first randomized controlled trial comparing two systems of medicine in stroke. The trial studied about the safety and efficacy of ayurvedic rehabilitative treatment in comparison with conventional physiotherapy in stroke rehabilitation across North and South India. The results showed that ayurvedic rehabilitative treatment was not superior to conventional physiotherapy for improving sensorimotor recovery in ischemic stroke patients, but it was safe to use. The process evaluation assessed the implementation of the trial and its specific rehabilitation effects.</p><p><strong>Methods: </strong>A mixed methods approach, incorporating qualitative in-depth interviews and quantitative data derived from case report forms and activity logs, was employed. Thirty-eight interviews of patient-caregiver dyads and health professionals were conducted. Thematic analysis of qualitative data was done with RE-AIM and realist models. The RE-AIM model aimed to evaluate the reach, effectiveness, adoption, implementation, and maintenance of the RESTORE trial. The context-mechanism-outcome configuration was used as the main structure for realist analysis.</p><p><strong>Results: </strong>Participants in the intervention (ayurvedic rehabilitative treatment) and control (physiotherapy) groups experienced advantages from the therapy, like improved mobility. In addition, the intervention group reported enhanced emotional stability and pain relief compared to the control group. Participants, particularly from South India, found ayurveda therapies more acceptable. In this study, three key reasons were identified for ayurvedic rehabilitative therapy not outperforming conventional physiotherapy. First, a standard ayurveda treatment protocol may not suit every patient as ayurveda emphasizes individualized care. Second, certain treatments like nasya were excluded due to safety concerns for stroke patients, likely affecting outcomes. Lastly, a 1-month duration of ayurveda treatment may be too short to enhance stroke recovery.</p><p><strong>Conclusion: </strong>This process evaluation suggests the need for further studies with a revised protocol that may lead to an important step in integrating ayurveda and physiotherapy in stroke rehabilitation in India.</p>","PeriodicalId":9683,"journal":{"name":"Cerebrovascular Diseases","volume":" ","pages":"1-9"},"PeriodicalIF":1.5000,"publicationDate":"2025-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Ayurvedic Treatment in the Rehabilitation of Ischemic Stroke Patients in India: A Randomized Controlled Trial (RESTORE) - Findings from the Process Evaluation.\",\"authors\":\"Pheba Susan Raju, Shweta Jain Verma, Aneesh Dhasan, Deepti Arora, Jeyaraj Durai Pandian, Vivek Nambiar, Sunil Narayan, Veena Babu, Meenakshi Sharma, Padmavathy Narayanan Sylaja\",\"doi\":\"10.1159/000547133\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>The RESTORE trial was the first randomized controlled trial comparing two systems of medicine in stroke. The trial studied about the safety and efficacy of ayurvedic rehabilitative treatment in comparison with conventional physiotherapy in stroke rehabilitation across North and South India. The results showed that ayurvedic rehabilitative treatment was not superior to conventional physiotherapy for improving sensorimotor recovery in ischemic stroke patients, but it was safe to use. The process evaluation assessed the implementation of the trial and its specific rehabilitation effects.</p><p><strong>Methods: </strong>A mixed methods approach, incorporating qualitative in-depth interviews and quantitative data derived from case report forms and activity logs, was employed. Thirty-eight interviews of patient-caregiver dyads and health professionals were conducted. Thematic analysis of qualitative data was done with RE-AIM and realist models. The RE-AIM model aimed to evaluate the reach, effectiveness, adoption, implementation, and maintenance of the RESTORE trial. The context-mechanism-outcome configuration was used as the main structure for realist analysis.</p><p><strong>Results: </strong>Participants in the intervention (ayurvedic rehabilitative treatment) and control (physiotherapy) groups experienced advantages from the therapy, like improved mobility. In addition, the intervention group reported enhanced emotional stability and pain relief compared to the control group. Participants, particularly from South India, found ayurveda therapies more acceptable. In this study, three key reasons were identified for ayurvedic rehabilitative therapy not outperforming conventional physiotherapy. First, a standard ayurveda treatment protocol may not suit every patient as ayurveda emphasizes individualized care. Second, certain treatments like nasya were excluded due to safety concerns for stroke patients, likely affecting outcomes. Lastly, a 1-month duration of ayurveda treatment may be too short to enhance stroke recovery.</p><p><strong>Conclusion: </strong>This process evaluation suggests the need for further studies with a revised protocol that may lead to an important step in integrating ayurveda and physiotherapy in stroke rehabilitation in India.</p>\",\"PeriodicalId\":9683,\"journal\":{\"name\":\"Cerebrovascular Diseases\",\"volume\":\" \",\"pages\":\"1-9\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2025-07-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cerebrovascular Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000547133\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cerebrovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000547133","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

RESTORE试验是首个比较两种卒中药物系统的随机对照试验。该试验研究了阿育吠陀康复治疗与传统物理治疗在印度北部和南部中风康复中的安全性和有效性。结果表明,阿育吠陀康复治疗在改善缺血性脑卒中患者感觉运动恢复方面并不优于常规物理治疗,但使用是安全的。该过程评估评估了试验的实施情况及其具体的康复效果。方法:采用混合方法,结合定性深入访谈和来自病例报告表格和活动日志的定量数据。对38名患者-护理人员和卫生专业人员进行了访谈。用RE-AIM和现实主义模型对定性数据进行专题分析。过程评估旨在通过RE-AIM模型评估RESTORE试验的覆盖范围、有效性、采用、实施和维护情况。情境-机制-结果(CMO)结构是现实性分析的主要结构。结果:干预(阿育吠陀康复治疗)组和控制(物理治疗)组的参与者从治疗中获得了优势,如活动能力改善。此外,与对照组相比,干预组的情绪稳定性和疼痛缓解有所提高。参与者,尤其是来自南印度的参与者,发现阿育吠陀疗法更容易被接受。在这项研究中,确定了阿育吠陀康复治疗没有优于传统物理治疗的三个关键原因。首先,标准的阿育吠陀治疗方案可能不适合每个病人,因为阿育吠陀强调个性化护理。其次,出于对中风患者安全性的考虑,nasya等某些治疗方法被排除在外,这可能会影响结果。最后,一个月的阿育吠陀治疗可能太短,无法促进中风的恢复。结论:这一过程评估表明,需要进一步研究修订后的方案,这可能导致印度卒中康复中整合阿育吠陀和物理治疗的重要一步。试验注册:RESTORE试验在印度临床试验注册中心(https://ctri.nic.in/Clinicaltrials/)注册,注册ID为CTRI/2018/04/013379,注册日期为2018年4月19日。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Ayurvedic Treatment in the Rehabilitation of Ischemic Stroke Patients in India: A Randomized Controlled Trial (RESTORE) - Findings from the Process Evaluation.

Introduction: The RESTORE trial was the first randomized controlled trial comparing two systems of medicine in stroke. The trial studied about the safety and efficacy of ayurvedic rehabilitative treatment in comparison with conventional physiotherapy in stroke rehabilitation across North and South India. The results showed that ayurvedic rehabilitative treatment was not superior to conventional physiotherapy for improving sensorimotor recovery in ischemic stroke patients, but it was safe to use. The process evaluation assessed the implementation of the trial and its specific rehabilitation effects.

Methods: A mixed methods approach, incorporating qualitative in-depth interviews and quantitative data derived from case report forms and activity logs, was employed. Thirty-eight interviews of patient-caregiver dyads and health professionals were conducted. Thematic analysis of qualitative data was done with RE-AIM and realist models. The RE-AIM model aimed to evaluate the reach, effectiveness, adoption, implementation, and maintenance of the RESTORE trial. The context-mechanism-outcome configuration was used as the main structure for realist analysis.

Results: Participants in the intervention (ayurvedic rehabilitative treatment) and control (physiotherapy) groups experienced advantages from the therapy, like improved mobility. In addition, the intervention group reported enhanced emotional stability and pain relief compared to the control group. Participants, particularly from South India, found ayurveda therapies more acceptable. In this study, three key reasons were identified for ayurvedic rehabilitative therapy not outperforming conventional physiotherapy. First, a standard ayurveda treatment protocol may not suit every patient as ayurveda emphasizes individualized care. Second, certain treatments like nasya were excluded due to safety concerns for stroke patients, likely affecting outcomes. Lastly, a 1-month duration of ayurveda treatment may be too short to enhance stroke recovery.

Conclusion: This process evaluation suggests the need for further studies with a revised protocol that may lead to an important step in integrating ayurveda and physiotherapy in stroke rehabilitation in India.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cerebrovascular Diseases
Cerebrovascular Diseases 医学-临床神经学
CiteScore
4.50
自引率
0.00%
发文量
90
审稿时长
1 months
期刊介绍: A rapidly-growing field, stroke and cerebrovascular research is unique in that it involves a variety of specialties such as neurology, internal medicine, surgery, radiology, epidemiology, cardiology, hematology, psychology and rehabilitation. ''Cerebrovascular Diseases'' is an international forum which meets the growing need for sophisticated, up-to-date scientific information on clinical data, diagnostic testing, and therapeutic issues, dealing with all aspects of stroke and cerebrovascular diseases. It contains original contributions, reviews of selected topics and clinical investigative studies, recent meeting reports and work-in-progress as well as discussions on controversial issues. All aspects related to clinical advances are considered, while purely experimental work appears if directly relevant to clinical issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信